‘War on terror’ has cost Pakistan $118bn: SBP

Published
53

KARACHI: Pakistan’s ‘war on terror’ has cost $118 billion so far, a new report by the State Bank has said.

The State Bank of Pakis­tan (SBP) in its annual report on Thursday showed that extre­mist violence cost the country $118.3bn in direct and indirect losses from 2002 to 2016.

“Both economic growth and social sector development have been severely ham­­pered by terrorism-related incidents,” the report said.

Pakistan became a pivotal US ally in the battle against extremism after the Sept 11, 2001 attacks spurred the US invasion of Afghanistan.

A Coalition Support Fund was approved by the US to support Pakistan in the war, with an annual release of around $1bn since 2002. By last year Pakistan had rece­ived a total of $14bn.

The SBP said that apart from causing immeasurable human suffering, including casualties and mass displacement, the war had helped drive away foreign investment, stall domestic investment, freeze exports, and slow down trade.

Published in Dawn November 19th, 2016

Opinion

Editorial

Nuclear uncertainty
Updated 23 Oct, 2026

Nuclear uncertainty

With matters frozen in the political and diplomatic spheres, it will take military-to-military engagement to prevent miscalculation in the strategic sphere.
Auto illusion
Updated 23 Oct, 2026

Auto illusion

PAKISTAN’S draft auto policy 2026-31 is ambitious in its targets and directionless in its strategy. It promises...
Two crimes
23 Oct, 2026

Two crimes

THE senseless killing of a teenager by his employers in Multan is a crime that deserves unqualified condemnation. It...
Makkah pact clarity
Updated 22 Oct, 2026

Makkah pact clarity

Fresh aggression can kick off a firestorm that will be in no one’s control, hence it is best to abandon such reckless plans.
Common ground
Updated 22 Oct, 2026

Common ground

Regrettably, the two sides still fail to see the country’s economic, security, and governance crises as challenges that must be solved politically.
The treatment gap
22 Oct, 2026

The treatment gap

A BREAST cancer diagnosis no longer carries the bleak outlook it did a generation ago. Targeted medicines,...